Login / Signup
Joy Fisher
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 7
Top Topics
Ejection Fraction
Patient Reported
High Grade
Metastatic Colorectal Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (10) (2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (10) (2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (10) (2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (10) (2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Karisa C Schreck
,
Strowd Re
,
Louis Burt Nabors
,
Benjamin M Ellingson
,
Michael Chang
,
Sze Kiat Tan
,
Zied Abdullaev
,
Rust Turakulov
,
Kenneth D Aldape
,
Neeraja Danda
,
Serena Desideri
,
Joy Fisher
,
Michaella Iacoboni
,
Trisha Surakus
,
Michelle A Rudek
,
Chetan Bettegowda
,
Stuart A Grossman
,
Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (10) (2024)